ANTHIM
Google image searchProduct monograph
Active ingredient
obiltoxaximab, 100 MG/ML
DIN: 02502895
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE USE VIAL
Schedule: Prescription / Schedule D
Company: ELUSYS THERAPEUTICS, INC.
Date: 13-SEP-2022
ATC:
- J06 — IMMUNE SERA AND IMMUNOGLOBULINS (ATC, ATC/DDD, )
- J06B — IMMUNOGLOBULINS (ATC, ATC/DDD)
- J06BC — Other immunoglobulins (ATC, ATC/DDD)
- J06BC04 — OBILTOXAXIMAB (ATC/DDD)
Reference brand drug: Anthim
Pharmaceutical standard: MFR
